| Tag | Content |
|---|
EnhancerAtlas ID | HS187-03161 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr10:35420660-35421710 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr10:35421224-35421245 | TTTGAATTTCACTTTTCATTT | + | 6.05 | | Sox6 | MA0515.1 | chr10:35421639-35421649 | CCATTGTTTT | + | 6.02 | | Zfx | MA0146.2 | chr10:35420903-35420917 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_20378 | chr10:35420346-35422351 | CD56 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH10I035130 | chr10 | 35419410 | 35422939 |
|
Enhancer Sequence | CTAATTCAGG TAGTTTATCT CCTTTGTCAG ATTTACTATC TAGTAGTTAA TACATTTATA 60
CTTAATACGT AGATATGTGT TTTCAGATGT ACTTAATGTG CAGTAAAGAA GCATGCTATT 120
GAAAACAAAA CAAAACAACC TTACAGTGAT TCTAGTCAAG CAAGTAACTC CTTCAAAAGT 180
TTAAAAATTT GGTTTCACAT TGGCCGGGTG CGGTGGCTCA CGCCTGTAAT CCCAGTGCTT 240
TGGGAGGCCG AGGCGGGCAA ATCAGGAGAC CAGCCTGACC AAACATGGTG AAACCCCGTC 300
TCTACTAAAA ATACAAAAAT TAGCTGGGCA TGGTGGCTCG CGCGTGTAAT CCCAGCTACT 360
CAGGAGACTG AGGCAGGAGA ATCGCTTGAA CCCGGGAGTT GGAGGTTGCA GTGAGCCGAG 420
ATCGTGCTAC TGCACTCCAT CCTGGGTGAT AGAGCGAGAC TTGAGTCTCA AAAAAAAAAA 480
AAAAAGAAAA AAAAATTGGT TTCACATGAA GTGGTGGTGG CGGGGGAGGG AGGTGTTTGA 540
AAGGATGGAG ACAGGCCATG ATTATTTGAA TTTCACTTTT CATTTCCTCC TCAGCAGCCC 600
ATTCTGTAGT TCATTTACTG TGAAATGGCC AAAAGCAGGC AGCATGTGGG AAATGAATTG 660
AAAAAGAGAC ACTTACTGAA TAGCTAGTCC TTTAGTGATT TTAGTAAAGA GTTAAGATTA 720
CTTAAATAAT AACAGGTGTC TCAGGCAATT AAATTGGAGT AGCCGTGAAT CTATATTAGA 780
GAGCCTCGTG AATTTATGTA TAATTCATGT TTGAAATATT AAAGACATTT ACAAGTGTTT 840
GGAATATTTA TTTACGAGTA TCCCTCTTGG CTATTCTGTT TTTACATGAA AGCGTAAAGA 900
TTATTTTTTG AAAGTTACTG TTACTTTGCT TCATAAAGAG TATAAGACCA ATGGTGTAAT 960
TTCATGGTAC TGCTTTCTCC CATTGTTTTT CCTGTACTCA TCTTCCCCTA AAATGCATAA 1020
CCATAGTCTC ATCCCCGTCA ATTGCAGCTA 1050
|
